The loneliest number: The Tipline for 8 December 2021

Martin Shrekli is on his own. Two of his fellow defendants – his former company and his former partner – have settled allegations that they illegally delayed generic competition for the life-saving drug Daraprim. Shkreli is not attending next week’s trial but, as per usual, “Pharma Bro” will be the centre of attention.

Get unlimited access to all Global Competition Review content